Leflunomide and Cilostazol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Leflunomide (leflunomide) and Cilostazol (cilostazol). Common drug interactions include septic shock among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Leflunomide and Cilostazol. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Leflunomide?

Leflunomide has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 82,105 Leflunomide users. Check the latest studies of Leflunomide.

What is Cilostazol?

Cilostazol has active ingredients of cilostazol. It is often used in arteriosclerosis of the extremities. eHealthMe is studying from 7,877 Cilostazol users. Check the latest studies of Cilostazol.



On Jul, 17, 2026

42 people who take Leflunomide and Cilostazol together, and have interactions are studied.

Leflunomide and Cilostazol drug interactions.

What are the common drug interactions of Leflunomide and Cilostazol, by gender? *:

female:

  1. Septic shock (shock due to blood infection)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Concussion (short loss of normal brain function in response to a head injury)
  4. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  5. Dry gangrene (diminished blood supply due to vascular problems)
  6. Fatigue (feeling of tiredness)
  7. Fibromyalgia (a long-term condition which causes pain all over the body)
  8. Gait disturbance
  9. Gastric disorder (disease of stomach)
  10. Gastrointestinal infection (infection of stomach and intestine)

male:

  1. Arthralgia (joint pain)
  2. Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
  3. Irritability
  4. Neuralgia (pain in one or more nerves)
  5. Death
  6. Ankylosing spondylitis (type of arthritis affecting the spine)
  7. Drug ineffective
  8. Ingrown hair
  9. Ligament sprain (ligament stretched)
  10. Pain

What are the common drug interactions of Leflunomide and Cilostazol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Back pain
  2. Dry gangrene (diminished blood supply due to vascular problems)
  3. Gastric disorder (disease of stomach)
  4. Syncope (loss of consciousness with an inability to maintain postural tone)

20-29:

n/a

30-39:

n/a

40-49:

  1. Arthralgia (joint pain)
  2. Sinusitis (inflammation of sinus)
  3. Weight increased
  4. Weight loss poor
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Gallbladder disorder
  7. Hypertension (high blood pressure)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Poor venous access
  10. Back pain

50-59:

  1. Arthralgia (joint pain)
  2. Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
  3. Impaired fasting glucose
  4. Latent tuberculosis (hidden tuberculosis)
  5. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  6. Rash erythematous (redness of the skin)
  7. Skin plaque (red, scaly patches to appear on the skin)
  8. Asthenia (weakness)
  9. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  10. Joint lock

60+:

  1. Insomnia (sleeplessness)
  2. Arthralgia (joint pain)
  3. Back pain
  4. Bacterial infection
  5. Balance disorder
  6. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Death
  9. Eczema nummular (circular or oval patches of eczema with well-defined edges)
  10. Fall

What are the existing conditions these people have? *

  1. High Blood Pressure: 14 people, 33.33%
  2. Stable Angina (a constant chest pain): 7 people, 16.67%
  3. Pain: 7 people, 16.67%
  4. Heart Disease: 6 people, 14.29%
  5. Takayasu's Arteritis (an inflammation of the aorta -- the artery that carries blood from the heart to the rest of the body): 5 people, 11.90%
  6. Osteoporosis (bones weak and more likely to break): 4 people, 9.52%
  7. Migraine (headache): 4 people, 9.52%
  8. Insomnia (sleeplessness): 4 people, 9.52%
  9. Thyroid Diseases: 3 people, 7.14%
  10. Psychotic Disorder Due To A General Medical Condition: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Leflunomide and Cilostazol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Leflunomide and Cilostazol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Leflunomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cilostazol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Leflunomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cilostazol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on leflunomide and cilostazol (the active ingredients of Leflunomide and Cilostazol, respectively), and Leflunomide and Cilostazol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: